The mode of topical immunomodulators in the immunological network of atopic dermatitis
- 1 March 2005
- journal article
- review article
- Published by Wiley in Clinical and Experimental Dermatology
- Vol. 30 (2), 160-164
- https://doi.org/10.1111/j.1365-2230.2005.01709.x
Abstract
For a long time, therapeutic strategies of atopic dermatitis (AD) have been dominated by the application of local or systemic steroids or other immunosuppressive agents, which have been limited by their potential for unwanted local or systemic side effects. Recently, the use of a new generation of topical nonsteroidal, immunomodulatory drugs has revolutionized the therapeutic options of this often recalcitrant allergic-inflammatory skin disease. Research work has focused on the identification of the exact mode of action and the immune specificities of the so-called 'topical immunomodulators' (TIMs) such as tacrolimus and pimecrolimus in AD. In addition to the previous findings about the mode of action of TIMs on T cells, other target cells of TIMs such as keratinocytes, mast cells, eosinophils and dendritic cells have been identified recently as potential therapeutic targets. In this overview, we provide a research update about the anti-inflammatory and anti-allergic properties of TIMs on effector cells of AD that may be involved in the complex pathophysiology of AD.Keywords
This publication has 32 references indexed in Scilit:
- Immune mechanisms leading to atopic dermatitisJournal of Allergy and Clinical Immunology, 2003
- Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitisJournal of Allergy and Clinical Immunology, 2001
- Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and TacrolimusDermatology, 2001
- Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506)Journal of Allergy and Clinical Immunology, 2001
- FK506, An Immunosuppressant Targeting Calcineurin FunctionCurrent Medicinal Chemistry, 2000
- Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytesInflammation Research, 1999
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in theJournal of Dermatological Science, 1996
- Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseasesThe Lancet, 1995
- The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytesJournal of Dermatological Science, 1995